| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immune Therapeutics, Inc. | COO and ICEO and IP, 10%+ Owner | Common Stock | 15,607,998 | 25 Jul 2022 | By Murphy Advisors, Inc. | ||
| Immune Therapeutics, Inc. | COO and ICEO and IP, 10%+ Owner | Common Stock | 3,696,947 | 25 Jul 2022 | By spouse | ||
| Immune Therapeutics, Inc. | COO and ICEO and IP, 10%+ Owner | Common Stock | 500 | 25 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390022080137-wilson-kelly-o-brien-2022-07-25 | Immune Therapeutics, Inc. | 25 Jul 2022 | 0 | $0 | 3 | COO and ICEO and IP, 10%+ Owner | 15 Dec 2022, 15:44 |